相关实验视频
Updated: Jun 3, 2025

07:01
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
Published on: April 17, 2013
21.0K
贝塞斯达III和IV甲状腺结节中的分子突变和临床行为:一项比较研究
Alexandra E Payne1, Coralie Lefebvre2, Michael Minello2
1Faculty of Arts and Sciences, Duke University, Durham, NC 27708, USA.
Cancers
|January 8, 2025
概括
分子分析揭示了贝塞斯达III和IV甲状腺结节之间的明显差异. 贝塞斯达IV结节显示出更多的副本数变化和独特的基因表达,而贝塞斯达III结节与BRAFV600E突变表明了侵略性癌症.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 分子诊断学 分子诊断
背景情况:
- 甲状腺癌是最常见的内分泌恶性瘤,需要准确的诊断.
- 贝塞斯达系统对甲状腺结节进行了分类,不确定的III和IV类构成诊断挑战.
- 了解不确定的甲状腺结节的分子概况可以改善诊断和治疗.
研究的目的:
- 为了研究贝塞斯达III和IV甲状腺结节之间的分子差异.
- 评估分子分析在区分不确定的甲状腺结节类别中的有用性.
- 为了将分子发现与临床和病理特征相关联.
主要方法:
- 对217名贝塞斯达III/IV结节患者的回顾性分析.
- ThyroSeq v3对突变,CNA和GEP进行分子测试.
- 分子数据与临床病理特征的相关性.
主要成果:
- 与贝塞斯达III相比,贝塞斯达IV结节显示CNA和独特的GEP的流行率更高.
- 该BRAFV600E突变仅在贝塞斯达III结节中发现.
- 贝塞斯达III结节中的BRAFV600E突变与更具侵略性的恶性行为相关.
结论:
- 分子分析 (CNA,GEP,突变) 提供了宝贵的洞察力Bethesda III/IV甲状腺结节.
- 独特的分子特征区分贝塞斯达III和IV结节.
- 分子分析可以提高诊断准确度,并为甲状腺癌量身定制治疗.
相关概念视频
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Synthesis and Regulation of Thyroid Hormones
4.2K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.2K
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
Mutations
79.5K
Overview
79.5K
Cancers Originate from Somatic Mutations in a Single Cell
11.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.5K
The Nucleolus
8.7K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.7K

